Clinical trial
Clinical Study of Evaluating the Safety and Initial Efficacy of XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
NCT06147505 is registered in ClinicalTrials.gov with Dushu Lake Hospital Affiliated to Soochow University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Evaluating the Safety and Initial Efficacy of XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
- Lead sponsor
- Dushu Lake Hospital Affiliated to Soochow University
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- October 29, 2023
- Completion date
- August 31, 2026
- Enrollment
- 13 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tumor